Your browser doesn't support javascript.
loading
Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy: A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, CTONG1304).
Song, Yong; Wu, Yi-Long; Cao, Le-Jie; Chen, Jian-Hua; Ma, Zhi-Yong; Cui, Jiu-Wei; Wang, Jie; Liu, Hong-Bing; Ding, Jing-Yan; Hu, Min.
Afiliação
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital/Guangdong Academy of Medical Sciences, Guangzhou.
  • Cao LJ; Department of Respiratory Medicine, The First Affiliated Hospital of USTC, Hefei.
  • Chen JH; Department of Medical Oncology, Hunan Cancer Hospital, Changsha.
  • Ma ZY; Department of Medical Oncology, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou.
  • Cui JW; Department of Medical oncology, First Hospital of Jilin University, Changchun.
  • Wang J; Department of Medical oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing.
  • Liu HB; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing.
  • Ding JY; IMED Asia, AstraZeneca.
  • Hu M; Dizal (Shanghai) Pharmaceutical Co., Ltd, Shanghai, China.
Am J Clin Oncol ; 42(5): 432-439, 2019 05.
Article em En | MEDLINE | ID: mdl-30950859
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Carcinoma Pulmonar de Células não Pequenas / Gefitinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Carcinoma Pulmonar de Células não Pequenas / Gefitinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article